(Q35943928)

11 August 2017

A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas (English)

1 reference

multicenter clinical trial

11 August 2017

0 references

author name string

Tomokazu Aoki

1

1 reference

11 August 2017

Ryo Nishikawa

2

1 reference

11 August 2017

Kazuhiko Sugiyama

3

1 reference

11 August 2017

Naosuke Nonoguchi

4

1 reference

11 August 2017

Noriyuki Kawabata

5

1 reference

11 August 2017

Kazuhiko Mishima

6

1 reference

11 August 2017

Jun-ichi Adachi

7

1 reference

11 August 2017

Kaoru Kurisu

8

1 reference

11 August 2017

Fumiyuki Yamasaki

9

1 reference

11 August 2017

Teiji Tominaga

10

1 reference

11 August 2017

Toshihiro Kumabe

11

1 reference

11 August 2017

Keisuke Ueki

12

1 reference

11 August 2017

Fumi Higuchi

13

1 reference

11 August 2017

Tetsuya Yamamoto

14

1 reference

11 August 2017

Eiichi Ishikawa

15

1 reference

11 August 2017

Hideo Takeshima

16

1 reference

11 August 2017

Shinji Yamashita

17

1 reference

11 August 2017

Kazunori Arita

18

1 reference

11 August 2017

Hirofumi Hirano

19

1 reference

11 August 2017

Shinobu Yamada

20

1 reference

11 August 2017

Masao Matsutani

21

1 reference

11 August 2017

NPC-08 study group

22

1 reference

11 August 2017

language of work or name

1 reference

29 November 2013

1 reference

Neurologia Medico-chirurgica

11 August 2017

1 reference

11 August 2017

54

1 reference

11 August 2017

4

1 reference

11 August 2017

290-301

1 reference

Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533485

Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24739422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2176/NMC.OA2013-0112

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

24739422

1 reference